As axon guidance pathways have been shown to be critical regulators of invasion and metastasis in other cancers (Neufeld et al., 2016), it will also be imperative to evaluate the effects of SEMA pathway genes on Group 3 and Group 4 MB motility and metastasis. Here, SEMA3B is linked to cancer.